These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19746665)

  • 1. Safety of ponazuril 15% oral paste in horses.
    Kennedy T; Campbell J; Selzer V
    Vet Ther; 2001; 2(3):223-31. PubMed ID: 19746665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.
    Furr M; Kennedy T; MacKay R; Reed S; Andrews F; Bernard B; Bain F; Byars D
    Vet Ther; 2001; 2(3):215-22. PubMed ID: 19746664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic administration of ponazuril reduces clinical signs and delays seroconversion in horses challenged with Sarcocystis neurona.
    Furr M; McKenzie H; Saville WJ; Dubey JP; Reed SM; Davis W
    J Parasitol; 2006 Jun; 92(3):637-43. PubMed ID: 16884012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-day toxicity study of toltrazuril 5% suspension in the horse.
    Furr MO; Quance J; Kennedy T
    Vet Ther; 2000; 1(4):245-51. PubMed ID: 19757571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid and serum concentrations of ponazuril in horses.
    Furr M; Kennedy T
    Vet Ther; 2001; 2(3):232-7. PubMed ID: 19746666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical field efficacy and safety of pyrantel pamoate paste (19.13% w/w pyrantel base) against Anoplocephala spp. in naturally infected horses.
    Marchiondo AA; White GW; Smith LL; Reinemeyer CR; Dascanio JJ; Johnson EG; Shugart JI
    Vet Parasitol; 2006 Apr; 137(1-2):94-102. PubMed ID: 16434142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target animal safety and tolerance study of pyrantel pamoate paste (19.13% w/w pyrantel base) administered orally to horses.
    Marchiondo AA; TerHune TN; Herrick RL
    Vet Ther; 2005; 6(4):311-24. PubMed ID: 16550493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of coadministration of corn oil and ponazuril on serum and cerebrospinal fluid concentrations of ponazuril in horses.
    Furr M; Kennedy T
    J Vet Intern Med; 2020 May; 34(3):1321-1324. PubMed ID: 32301131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
    Furr M; Kennedy T
    Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of efficacy of praziquantel horse paste 9% against tapeworms and its safety in horses.
    Slocombe JO; Heine J; Barutzki D; Slacek B
    Vet Parasitol; 2007 Mar; 144(3-4):366-70. PubMed ID: 17101225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ponazuril after oral administration to healthy llamas (Lama glama).
    Prado ME; Ryman JT; Boileau MJ; Martin-Jimenez T; Meibohm B
    Am J Vet Res; 2011 Oct; 72(10):1386-9. PubMed ID: 21962282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic approaches for equine protozoal myeloencephalitis: pharmacokinetics of diclazuril sodium salts in horses.
    Dirikolu L; Karpiesiuk W; Lehner AF; Hughes C; Woods WE; Harkins JD; Boyles J; Atkinson A; Granstrom DE; Tobin T
    Vet Ther; 2006; 7(1):52-63, 72. PubMed ID: 16598684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of an oral chondroprotective agent in horses.
    Kirker-Head CA; Kirker-Head RP
    Vet Ther; 2001; 2(4):345-53. PubMed ID: 19746657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ponazuril against Theileria equi.
    Wise LN; Ueti MW; Kappmeyer LS; Hines MT; White SN; Davis W; Knowles DP
    Vet Parasitol; 2012 Apr; 185(2-4):282-5. PubMed ID: 22130334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasitemia in an immunocompetent horse experimentally challenged with Sarcocystis neurona sporocysts.
    Rossano MG; Schott HC; Murphy AJ; Kaneene JB; Sellon DC; Hines MT; Hochstatter T; Bell JA; Mansfield LS
    Vet Parasitol; 2005 Jan; 127(1):3-8. PubMed ID: 15619368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical test and safety evaluations of an oral paste preparation of mebendazole and trichlorfon in horses.
    Seibert BP; Newcomb KM; Michael BF
    Am J Vet Res; 1986 Jun; 47(6):1347-50. PubMed ID: 3524328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a single dose of ponazuril on neural infection and clinical disease in Sarcocystis neurona-challenged interferon-gamma knockout mice.
    Franklin RP; MacKay RJ; Gillis KD; Tanhauser SM; Ginn PE; Kennedy TJ
    Vet Parasitol; 2003 May; 114(2):123-30. PubMed ID: 12781474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to Sarcocystis neurona infection in naturally infected horses with equine protozoal myeloencephalitis.
    Yang J; Ellison S; Gogal R; Norton H; Lindsay DS; Andrews F; Ward D; Witonsky S
    Vet Parasitol; 2006 Jun; 138(3-4):200-10. PubMed ID: 16563631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and detection of toltrazuril sulfone and its pharmacokinetics in horses following administration in dimethylsulfoxide.
    Dirikolu L; Karpiesiuk W; Lehner AF; Hughes C; Granstrom DE; Tobin T
    J Vet Pharmacol Ther; 2009 Aug; 32(4):368-78. PubMed ID: 19614842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical toxicosis and erythrocyte cholinesterase inhibition of trichlorfon combined with mebendazole in horses.
    Gingerich DA; Mia AS
    Am J Vet Res; 1981 Sep; 42(9):1645-50. PubMed ID: 7325477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.